Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
23.40
-1.69 (-6.74%)
May 13, 2025, 4:00 PM - Market closed
Pacira BioSciences Employees
As of December 31, 2024, Pacira BioSciences had 790 total employees, including 788 full-time and 2 part-time employees. The number of employees increased by 78 or 10.96% compared to the previous year.
Employees
790
Change (1Y)
78
Growth (1Y)
10.96%
Revenue / Employee
$889,585
Profits / Employee
-$131,300
Market Cap
1.08B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PCRX News
- 20 hours ago - Lawsuit for Investors in shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) announced by the Shareholders Foundation - PRNewsWire
- 21 hours ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRA) And Encourages Shareholders to Reach Out - Accesswire
- 2 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRA) and Encourages Investors to Learn More About the Investigation - Accesswire
- 5 days ago - Pacira BioSciences, Inc. (PCRX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Pacira BioSciences Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 5 days ago - Pacira BioSciences, Inc. (PCRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 7 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRA) And Encourages Investors to Connect - Accesswire
- 9 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRA) Stockholders to Inquire about Securities Investigation - Accesswire